Accuracy of the ICD-10 discharge diagnosis for syncope

Size: px
Start display at page:

Download "Accuracy of the ICD-10 discharge diagnosis for syncope"

Transcription

1 Europace (2013) 15, doi: /europace/eus359 CLINICAL RESEARCH Syncope and implantable loop recorders Accuracy of the ICD-10 discharge diagnosis for syncope Martin Huth Ruwald 1 *, Morten Lock Hansen 2, Morten Lamberts 1, Søren Lund Kristensen 1, Mads Wissenberg 1, Anne-Marie Schjerning Olsen 1, Stefan Bisgaard Christensen 1, Michael Vinther 1, Lars Køber 3, Christian Torp-Pedersen 1, Jim Hansen 1, and Gunnar Hilmar Gislason 1 1 Department of Cardiology, Copenhagen University Hospital, Gentofte, Denmark; 2 Department of Cardiology, Copenhagen University Hospital, Herlev, Denmark; and 3 Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Denmark Received 9 August 2012; accepted after revision 3 October 2012; online publish-ahead-of-print 4 November 2012 Aims Administrative discharge codes are widely used in epidemiology, but the specificity and sensitivity of this coding is unknown and must be validated. We assessed the validity of the discharge diagnosis of syncope in administrative registers and reviewed the etiology of syncope after workup.... Methods Two samples were investigated. One sample consisted of 5262 randomly selected medical patients. The other sample and results consisted of 750 patients admitted or seen in the emergency department (ED) for syncope (ICD-10: R55.9) in three hospitals in Denmark. All charts were reviewed for baseline characteristics and to confirm the presence/absence of syncope and to compare with the administrative coding. In a sample of 600 admitted patients 570 (95%) and of 150 patients from ED 140 (93%) had syncope representing the positive predictive values. Median age of the population was 69 years (IQR: +14). In the second sample of 5262 randomly selected medical patients, 75 (1.4%) had syncope, of which 47 were coded as R55.9 yielding a sensitivity of 62.7%, a negative predictive value of 99.5%, and a specificity of 99.9%.... Conclusion ED and hospital discharge diagnostic coding for syncope has a positive predictive value of 95% and a sensitivity of 63% Keywords Syncope Epidemiology Validity Introduction Syncope is a common condition associated with frequent hospitalizations or emergency department (ED) visits. 1 4 It is difficult to evaluate and is associated with a high mortality rate in selected subgroups of patients Hospital discharge diagnoses are frequently used to identify syncope subjects in epidemiological observational studies, but no validation studies have been carried out on the International Classification of Diseases (ICD), 1994, the 10th revision (ICD-10) discharge diagnosis. Syncope is in the ICD-10 coding system coded as R55.9 (syncope and collapse). Some patients with syncope and an underlying predisposing disorder may have the discharge diagnosis classified elsewhere such as patients experiencing syncope due to aortic stenosis, myocardial infarction, ventricular tachycardia, and similar disorders. Prospective syncope observational programs are extremely rare, primarily because of the high cost and therefore administrative registries have become a highly sought after source of data for disease observation, assessment of health resource consumption, and evaluation of outcomes. The potential benefits of administrative databases are their sizes and rich contents, particularly when combined with other administrative databases. Information on hospitalization and comorbidities from the Danish National Patient Register, where information on all hospital admissions in Denmark has been registered since 1978, is widely used in Danish epidemiological research. 12 At discharge, each * Corresponding author. Tel: , mruwald@hotmail.com Published on behalf of the European Society of Cardiology. All rights reserved. & The Author For permissions please journals.permissions@oup.com.

2 596 M.H. Ruwald et al. What s new The International Classification of Diseases (ICD), 1994, the 10th revision (ICD-10) discharge diagnosis of syncope, R55.9 has a positive predictive value of 95%. The ICD-10 discharge diagnosis of syncope, R55.9 has a sensitivity of 63% and excludes some with a more severe diagnosis. Validation of the administrative coding of syncope yields a tool for epidemiological surveillance. hospital admission is coded with one primary diagnosis and if appropriate one or more secondary diagnoses according to the ICD-10. Validation of ICD-coded discharge data from EDs and hospitals is one important step towards developing a valid and accurate case definition for a condition of interest for future observations. To our knowledge only one study has previously examined syncope discharge diagnosis. Sun et al. 4 validated the discharge diagnosis of ICD-9-CM code (comparable with ICD-10 diagnosis R55.9) in the USA, finding a positive predictive value of 92% of identifying patients with syncope or near syncope. We undertook a syncope validation and review study with a primary objective of determining the accuracy of syncope discharge coding in the setting of three Danish hospitals. Methods Two samples were investigated Sample 1 We retrospectively identified a cohort of subjects who underwent admission or was seen in an ED for medical reasons from 1 to 31 January 2008 in three university hospitals in the Capital Region of Copenhagen. A total of 4045 charts of admitted patients and 1255 ED patients were identified through the electronic patient management system, of which 38 charts could not be accessed yielding a total of 5262 reviewed charts. These charts were divided among the authors who all used the latest definition of syncope according to the European Society of Cardiology (ESC) as a screening tool for syncope in the recorded history of the actual cause of hospitalization or referral. This sample was used for calculation of the sensitivity, negative predictive value, and specificity. Inter-observer variation was done by blinding two reviewers and comparing their results from the review of 200 charts. Sample 2 To obtain a valid positive predictive value and to record baseline characteristics for the syncope patients we retrospectively identified a cohort of subjects who underwent a hospitalization for syncope according to the R55.9 diagnosis (primary or most responsible discharge diagnosis only) from 1 January 2007 to 31 December 2010 in the same three hospitals. A total of 1223 charts of admitted patients with syncope were identified through the electronic patient management system, 23 charts were insufficient for documentation or the chart could not be accessed by the reviewers. From this overall syncope population of 1200, we randomly selected 50% from each hospital of the total admitted patients for individual validation of their syncope, while a random selection of 50 patients per hospital for a total of 150 was used for ED validation. Next, we calculated the positive predictive value for the sample and analyzed the results within subgroups based on type of hospital and type of contact. For each patient, we determined if the hospital chart documentation satisfied the definition and diagnosis of syncope according to the ESC. 13 The current definition of syncope is a total loss of consciousness (T-LOC) characterized by a rapid onset, short duration, and spontaneous complete recovery. Those presenting a traumatic cause for T-LOC were excluded as well as epileptic seizures and psychogenic T-LOC, thus not fulfilling the criteria for syncope. The term addressed pre-syncopal or near-syncope characterized by lightheadedness, nausea, and weakness was not considered sufficient to fulfil the criteria. Hospitals chosen for validation Of the three hospitals, one is a major centre of cardiology with a specialized syncope unit and catheter laboratory for pacemaker implantations, coronary angiography, and cardiac ablations, while the other two are representatives of large volume hospitals with large open-referral EDs and designated departments of internal medicine and neurology. All charts from admitted patients were read independently, reviewing all notes from the physician history and physical examination, physicians notes during rounds and at discharge. On the basis of this information and the presence or absence of syncope each individual was assigned to each chart. The reviews were divided among the reviewers (mean value 501 charts per reviewer). Statistics Patient demographics (age, sex, pharmacotherapy, and comorbidity) were analysed for all patients identified as having syncope based on the administrative coding in the database. Student s t-tests and chi-square tests were used to assess differences between patients included in the chart review. The validity of the coding was described as positive predictive value defined as the proportion of patients that actually had the condition by a positive history of syncope in the chart with an administrative coding of syncope. The sensitivity was calculated in the first sample by dividing the total amount of patients with syncope recorded as R559 with the total amount of syncope as found in the review. All data management and analyses were conducted using SAS Version 9.2 (SAS Institute, Inc., Cary, NC, USA), and findings with P, 0.05 were considered statistically significant. Ethics The study was approved by the Danish Data Protection Agency (ref , int. ref: GEH ). Ethical approval in retrospective register-based analysis is not compulsory in Denmark. Results A total of 750 charts from patients with syncope (R559) were reviewed systematically: 150 ED charts and 600 inpatient charts, revealing 140 and 570 cases fulfilling syncope criteria, respectively. The calculated positive predictive value of the administrative coding was high with a positive predictive value of 93% in an ED and 95% in admitted patients. The numbers of patient charts per hospital and patient baseline characteristics of comorbidities and pharmacotherapy are presented in Table 1. The median age of the

3 Accuracy of the ICD-10 discharge diagnosis for syncope 597 Table 1 Baseline characteristics Characteristics Number (%) Number (%) Hospital 1 Number (%) Number (%) Hospital 3 Total Internal medicine and Hospital 2 Internal medicine, neurology departments Cardiology cardiology and neurology departments... Number of patients 570 (100) 171 (30) 158 (27.7) 241 (42.3) Men 297 (52) 82 (48) 89 (56) 126 (52) Age years (IQR) 68.5 (53 81) 65 (40 80) 68 (52 80) 70 (57 82) Previous syncope 130 (23) 39 (23) 39 (25) 52 (22) Prodromal symptoms 249 (44) 87 (51) 50 (32) 112 (46) Comorbidities Ischaemic heart disease 126 (22) 37 (22) 33 (21) 56 (23) Peripheral vascular disease 78 (14) 30 (18) 26 (16) 22 (9) Previous myocardial infarction 87 (15) 23 (13) 23 (15) 41 (17) Systemic hypertension 288 (51) 83 (49) 87 (55) 118 (49) Previous or current atrial fibrillation 77 (14) 19 (11) 27 (17) 31 (13) Other arrhythmias 37 (6) 11 (6) 13 (8) 13 (5) Previous stroke 72 (13) 21 (12) 11 (7) 40 (17) Congestive heart failure 61 (11) 17 (10) 20 (13) 24 (10) Previous or ongoing cancer 49 (9) 18 (11) 8 (5) 23 (10) Chronic obstructive pulmonary disorder 46 (8) 16 (9) 10 (6) 20 (8) Diabetes 56 (10) 18 (11) 14 (9) 24 (10) Cardiac pacemaker or ICD unit 21 (4) 6 (4) 4 (3) 11 (5) Epilepsy 7 (1) 2 (1) 3 (2) 2 (1) Alcoholism 18 (3) 10 (6) 1 (1) 7(3) Dementia 29 (5) 9 (5) 4 (3) 16 (7) Depression 25 (4) 2 (1) 1 (1) 22 (9) Previous PCI or CABG 61 (11) 17 (10) 18 (11) 26 (11) Previous or current smoker 223 (39) 78 (46) 56 (35) 89 (37) Alcohol intake above recommended level 124 (22) 57 (33) 27 (17) 40 (17) Pharmacotherapy Statins 148 (26) 39 (23) 45 (28) 64 (27) Aspirin 188 (33) 43 (25) 60 (38) 85 (35) Platelet inhibitors 57 (10) 19 (11) 11 (7) 27 (11) Beta-blockers 140 (25) 34 (20) 40 (25) 66 (27) ACEI/ARB 210 (37) 62 (36) 56 (35) 92 (38) Digoxin 21 (4) 4 (2) 6 (4) 11 (5) Nitrates 34 (6) 12 (7) 9 (6) 13 (5) Calcium channel blockers 85 (15) 26 (15) 28 (18) 31 (13) Spironolactone 21 (4) 5 (3) 4 (3) 12 (5) Thiazide 111 (19) 24 (14) 36 (23) 51 (21) Loop diuretics 85 (15) 22 (13) 25 (16) 38(16) VKA 35 (6) 9 (5) 10 (6) 16 (7) Class Ic antiarrhythmic drugs 1 (0) 0 (0) 0 (0) 1 (0) Class III antiarrhythmic drugs 13 (2) 5 (3) 6 (4) 2 (1) Bronchial dilators 42 (7) 15 (9) 8 (5) 19 (8) Anxiolytics 56 (10) 20 (12) 13 (8) 23 (10) Antipsychotics 27 (5) 10 (6) 6 (4) 11 (5) Antidepressants 76 (13 22 (13) 14 (9) 40 (17) Glucose-lowering drugs 51 (9) 15 (9) 10 (6) 26 (11) Non-steroidal anti-inflammatory drugs 40 (7) 18 (11) 9 (6) 13 (5) Morphine a 37 (7) 14 (8) 5 (3) 18 (7) ICD, implantable cardioverter defibrillator; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; VKA, vitamin K antagonists. a Morphine use was appropriate in all patients taking morphine. Age is given in median and interquartile range (IQR).

4 598 M.H. Ruwald et al. Table 2 Validity of the principal discharge diagnosis of syncope R55.9 All medical patients... Syncope positive Syncope negative... Test outcome R559 True positive (TP) ¼ 47 False positive (FP) ¼ 2 Positive predictive value ¼TP/(TP + FP) ¼47/(47 + 1) ¼95.9% Other diagnosis False negative (FN) ¼ 28 True negative (TN) ¼ 5185 Negative predictive value ¼TN/(FN + TN) ¼5185/( ) 99.5% Sensitivity Specificity ¼TP/(TP + FN) ¼TN/(FP + TN) ¼47/( ) ¼5185/( ) 62.7% ¼99.9% A more precise positive predictive value was found by reviewing 600 charts from admitted patients only with R559 diagnosis, revealing 570 true syncope ¼ 570/600 ¼ 95.0%. The positive predictive value of syncope in an ED was found to be 93.3 (140 out of 150). Table 3 Other discharge codes used where syncope was one of the predominant symptoms ICD-10 code Diagnosis Number (contributing percentage)... I495 Sick sinus node syndrome 4 (8.5%) Z033 Observation on suspicion of neurological disease 3 (6.4%) I214 Non-ST-elevation acute myocardial infarction with no Q-wave 3 (6.4%) I649, I951, J189, K290, Z039, R298, I455, I489, I350, I422, J969, Z034, I459, I210, K553, I509, T430 Cerebral infarction, orthostatic hypotension, pneumonia, acute bleeding gastritis, symptom from the nervous system, observation on suspicion of disease, unspecified heart block, atrial fibrillation, aortic stenosis, hypertrophic cardiomyopathy, insufficient respiration, observation on suspicion of myocardial infarction, Adam-stokes syndrome, anterior myocardial infarction with Q-wave, unspecified heart failure, poisoning with tricyclic antidepressives patients was 68.5 years [interquartile range (IQR): years, and 48% of them were female. Of the 570 patients; a history of hypertension was present in 51%, ischaemic heart disease in 22%, atrial fibrillation in 14%, congestive heart failure in 11%, and diabetes in 10%. No major differences between the three hospitals were seen in terms of comorbidities or pharmacotherapy. The sensitivity was calculated through validation of the first sample revealing 75 (1.4%) cases of syncope of which 47 (62.7%) were coded as R559. The negative predictive value and the specificity were as high as 99%. The terms are presented in Table 2. Inter-observer variation was compared in two blinded reviewers and no disagreement was found. Roughly one-third (28 patients) of patients with syncope as a primary or significantly contributing symptom are thus coded as other discharge diagnoses. The discharge diagnoses most often used was I49.5 (8.5%) sick sinus node syndrome, Z03.3 (6.4%) observation on suspicion of neurologic disease, and I21.4 (6.4%) non-st-elevation acute myocardial infarction with no Q-wave. Other codes used as discharge diagnoses covering the remaining cases of syncope are presented in Table 3. Discussion 1 (2.1%) The objective of this study was to determine whether the administrative coding of syncope could accurately be used to identify patients with syncope. The major finding of the study was a very high validity and positive predictive value (95%) of the principal discharge diagnosis of syncope R55.9. Another important finding is that 62.7% of cases with syncope are covered by the discharge diagnosis of R55.9, whereas the remaining part of syncope is covered by a wide range of discharge diagnosis, mostly cardiologic, such as third-degree atrioventricular block, myocardial infarction, and some observation codes. To our knowledge, this study is the first to systematically validate administrative data against medical chart data for the identification of syncope, either admitted or seen in an ED. A high positive predictive value suggests that the proposed coding can be used to identify patients with syncope in administrative databases with a high level of accuracy, introducing the possibility of epidemiological surveillance, whereas one-third of patients suffering syncope are not included in the R55.9 diagnosis limiting the use of R55.9 when investigating

5 Accuracy of the ICD-10 discharge diagnosis for syncope 599 syncope as an outcome in epidemiological studies or in drugrelated adverse effects. However, reliable data can be extracted from this administrative coding regarding hospitalization costs due to syncope, in-hospital days, and estimations in general. The general evaluation of a patient with syncope involves a myriad of diagnostic tests, but the annual cost of syncope-related admissions is very hard to calculate as no administrative coding is specifically designed to syncope. It is, however, estimated that the annual costs of syncope-related admissions in the USA exceeds $2 billion. 14 Syncope accounted for 1.4% of all medically hospitalized patients which is comparable with other retrospective studies and to our recent study on nationwide incidence. 1,2,4,15,16 Validity Our findings support the notion that population-based hospital discharge administrative data can be used to identify a syncope cohort accurately. That is the only way appropriate adjustment for the prevalence and hospital incidence of syncope could be made. Syncope ICD-10 coding by physicians for ED visits and admission is accurate when looking at other mimics of syncope, such as pre-syncope, dizziness, vertigo, alcohol intoxication, exhaustion, epilepsy, transient ischaemic attack, hypoglyacemia, and convulsions. It should be noted that accordingly only 5% of patients are actually non-syncopal T-LOC and not true syncopes. Likewise it should be noted that 37% of all patients with syncope are missed in this diagnostic coding and thus are represented by other ICD-10 diagnoses. Accuracy of syncope coded in administrative data is high across all hospital settings. We showed that accuracy of syncope coding by physicians is high, whether the encounter (patient visit) was an ED visit or a hospital admission, and whether it was at a centre with a syncope clinic or a non-specialized unit. This probably reflects that physicians in these settings use the same coding guidelines throughout the health region and we would expect similar findings in other hospitals across the country. The finding corresponds with the lone validation study of administrative coding of syncope 4 from the USA. A high validity has been found in other countries of other conditions such as epilepsy, amyotrophic lateral sclerosis, and stroke, but other validation studies have proved that this cannot be extrapolated to all diseases or symptoms. 20,21 Based on our findings, registries can be used to identify patients with a general diagnosis of syncope accurately including a broad mixture of assumed aetiologies, but general inferences from coding cannot be made to identify any specific cause. Other discharge diagnosis codes used whenever syncope was a predominant symptom As suspected earlier this retrospective analysis R55.9 did not cover all cases of syncope. The findings that one-third of the patients received other discharge diagnoses were actually lower than that anticipated. Most of the other discharge diagnosis used were diagnoses with well-established aetiological and pathophysiological coherence to syncope as a symptom covering a wide spectrum of specific cardiac diseases but also less-specific observational coding. In other words we do not find the ICD-10 particularly helpful in terms of describing any established aetiological explanation to syncope. However, the possibility of using Adam stokes syndrome and orthostatic hypotension remain applicable in the ICD-10 system. Thus, the optimal description of aetiological considerations in syncope in the ICD-10 system is unfortunately at the moment to use either syncope R55.9 as the primary diagnosis and a secondary diagnosis that most accurately covers the cause of the syncope, such as aortic stenosis, myocardial infarction, and the like, or consequently use R55.9 as a secondary diagnosis whenever syncope is a predominant symptom. Limitations First, we assessed only ED and inpatient databases. A majority of syncope cases are treated in outpatient and general practitioner (GP) settings and generalizing our findings to outpatient or GP databases should not be done. Therefore, data from those individuals who do not seek medical attention or who are only seen in outpatient clinics or offices are not captured. For syncope, this results in a slight bias to more severe cases of syncope because patients with milder/less severe symptoms may not seek medical attention. Secondly, our gold standard relied solely on chart documentation. However, when admitted to an ED or in a hospital, patients tend to have more extensive workup. Therefore, the charts most likely reflected the true diagnoses. Conclusion In conclusion, ICD-10 coding for the identification of those with syncope who visit an ED or who are admitted to a hospital is highly specific. To identify a cohort of true syncope patients, the ICD-10 coding R55.9 can be used with a positive predictive value of 95% and a sensitivity of 63%. Conflict of interest: none declared. Funding This study was supported by an unrestricted grant from the Danish Heart Association (12-04-R90-A ) and the Lundbeck Foundation (R108-A10415). References 1. Sarasin FP, Louis-Simonet M, Carballo D, Slama S, Rajeswaran A, Metzger JT et al. Prospective evaluation of patients with syncope: a population-based study. Am J Med 2001;111: Quinn J, McDermott D, Kramer N, Yeh C, Kohn MA, Stiell I et al. Death after emergency department visits for syncope: how common and can it be predicted? Ann Emerg Med 2008;51: Day SC, Cook EF, Funkenstein H, Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 1982;73: Sun BC, Derose SF, Liang LJ, Gabayan GZ, Hoffman JR, Moore AA et al. Predictors of 30-day serious events in older patients with syncope. Ann Emerg Med 2009;54: e Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ et al. Incidence and prognosis of syncope. N Engl J Med 2002;347: Alshekhlee A, Shen WK, Mackall J, Chelimsky TC. Incidence and mortality rates of syncope in the United States. Am J Med 2009;122:181 8.

6 600 M.H. Ruwald et al. 7. Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. Q J Med 1985;55: Getchell WS, Larsen GC, Morris CD, McAnulty JH. Epidemiology of syncope in hospitalized patients. J Gen Intern Med 1999;14: Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore) 1990;69: Kapoor WN, Hanusa BH. Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. Am J Med 1996;100: Kapoor W, Snustad D, Peterson J, Wieand HS, Cha R, Karpf M. Syncope in the elderly. Am J Med 1986;80: Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish national hospital register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46: Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30: Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol 2005;95: Sun BC, Emond JA, Camargo CA Jr. Characteristics and admission patterns of patients presenting with syncope to U.S. Emergency Departments, Acad Emerg Med 2004;11: Ruwald MH, Hansen ML, Lamberts M, Hansen CM, Hojgaard MV, Kober L et al. The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study. Europace Kokotailo RA, Hill MD. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke 2005;36: Jette N, Reid AY, Quan H, Hill MD, Wiebe S. How accurate is ICD coding for epilepsy? Epilepsia 2010;51: Stickler DE, Royer JA, Hardin JW. Validity of hospital discharge data for identifying cases of amyotrophic lateral sclerosis. Muscle Nerve 2011;44: Pedersen M, Klarlund M, Jacobsen S, Svendsen AJ, Frisch M. Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry. Eur J Epidemiol 2004;19: Nielsen EH, Lindholm J, Laurberg P. Use of combined search criteria improved validity of rare disease (craniopharyngioma) diagnosis in a national registry. J Clin Epidemiol 2011;64:

The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study

The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study Europace (2012) 14, 1506 1514 doi:10.1093/europace/eus154 CLINICAL RESEARCH Syncope and implantable loop recorders The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope:

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL 1 Supplemental Table 1. ICD codes Diagnoses, surgical procedures, and pharmacotherapy used for defining the study population, comorbidity, and outcomes Study population Atrial fibrillation

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Olesen JB, Lip GYH, Kamper A-L, et al. Stroke and bleeding

More information

Psoriasis is associated with increased risk of incident Diabetes Mellitus: A Danish nationwide cohort study

Psoriasis is associated with increased risk of incident Diabetes Mellitus: A Danish nationwide cohort study Psoriasis is associated with increased risk of incident Diabetes Mellitus: A Danish nationwide cohort study Khalid U, Hansen PR, Gislason GH, Kristensen SL, Lindhardsen J, Skov L, Torp-Pedersen C, Ahlehoff

More information

Syncope evaluation: the role of syncope clinics Michele Brignole Arrhythmologic Centre, Lavagna, Italy

Syncope evaluation: the role of syncope clinics Michele Brignole Arrhythmologic Centre, Lavagna, Italy Syncope evaluation: the role of syncope clinics Michele Brignole Arrhythmologic Centre, Lavagna, Italy Why should we need a Syncope Management Unit? We are not happy with current strategies: - not standardized

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST The Management of Syncope remains a challenge: Clues from the History Richard Sutton, DSc Emeritus Professor of Cardiology Imperial College, St Mary s Hospital, London,

More information

Syncope Cardiac or not? Dr Jaycen Cruickshank Emergency Physician Director of Clinical Training BHS

Syncope Cardiac or not? Dr Jaycen Cruickshank Emergency Physician Director of Clinical Training BHS Syncope Cardiac or not? Dr Jaycen Cruickshank Emergency Physician Director of Clinical Training BHS Syncope( (cardiac(or(not?( What(is(syncope?( Syncope( is( a( brief( loss( of( consciousness( that( resolves(

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

Lee Chee Wan. Senior Consultant Pacing and Cardiac Electrophysiology. GP Symposium 2 nd April 2016

Lee Chee Wan. Senior Consultant Pacing and Cardiac Electrophysiology. GP Symposium 2 nd April 2016 Lee Chee Wan Senior Consultant Pacing and Cardiac Electrophysiology GP Symposium 2 nd April 2016 Objectives Definition of syncope Common causes of syncope & impacts How to clinically assess patient with

More information

Rapid Access Clinics for Transient Loss of Consciousness

Rapid Access Clinics for Transient Loss of Consciousness Rapid Access Clinics for Transient Loss of Consciousness Michael Gammage Department of Cardiovascular Medicine University of Birmingham and University Hospital Birmingham NHS Foundation Trust Those who

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Adenosine in idiopathic AV block, 445 446 Adolescent(s) syncope in, 397 409. See also Syncope, in children and adolescents AECG monitoring.

More information

An Approach to the Patient with Syncope. Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva

An Approach to the Patient with Syncope. Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva An Approach to the Patient with Syncope Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva Case presentation A 23 y.o. man presented with 2 episodes of syncope One during exercise,one at rest

More information

Atrial fibrillation (AF) is a disorder seen

Atrial fibrillation (AF) is a disorder seen This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lee C-C, Lee M-tG, Chen Y-S. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Internal Medicine. Published online October 5, 2015.

More information

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders GENERAL ISSUES REGARDING MEDICAL FITNESS-FOR-DUTY 1. These medical standards apply to Union Pacific Railroad (UPRR) employees

More information

134 Adrian Baranchuk, MD FACC 1, William McIntyre BSc MD 1, William Harper, MD 2, Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC 2.

134 Adrian Baranchuk, MD FACC 1, William McIntyre BSc MD 1, William Harper, MD 2, Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC 2. www.ipej.org 134 Original Article Application Of The American College Of Emergency Physicians (ACEP) Recommendations And a Risk Stratification Score (OESIL) For Patients With Syncope Admitted From The

More information

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview Pediatrics Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment See online here The most common form of cardiac arrhythmia in children is sinus tachycardia which can be caused by

More information

Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography

Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography Rebecka Karlsson Pardeep Jhund 1 Material and methods

More information

Condition/Procedure Measure Compliance Criteria Reference Attribution Method

Condition/Procedure Measure Compliance Criteria Reference Attribution Method Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GYH. Assessment of the CHA 2 DS 2 -VASc score in predicting ischemic stroke, thromboembolism, and death

More information

Syncope: Causes and Treatment

Syncope: Causes and Treatment March 01, 2006 By Avery Hayes, MD [1] and Mahendr S. Kochar, MD, MS [2] Because the causes of syncope are numerous and the diagnostic tests have low yield, this disorder is often difficult to evaluate.

More information

The Yield of Head CT in Syncope: A Pilot Study

The Yield of Head CT in Syncope: A Pilot Study The Yield of Head CT in Syncope: A Pilot Study The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Published Version Accessed

More information

Chapter 8: Cardiovascular Disease in Patients with ESRD

Chapter 8: Cardiovascular Disease in Patients with ESRD Chapter 8: Cardiovascular Disease in Patients with ESRD Cardiovascular disease (CVD) is common in adult end-stage renal disease (ESRD) patients, with coronary artery disease (CAD) and heart failure (HF)

More information

Congestive Heart Failure or Heart Failure

Congestive Heart Failure or Heart Failure Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?

More information

Polypharmacy - arrhythmic risks in patients with heart failure

Polypharmacy - arrhythmic risks in patients with heart failure Influencing sudden cardiac death by pharmacotherapy Polypharmacy - arrhythmic risks in patients with heart failure Professor Dan Atar Head, Dept. of Cardiology Oslo University Hospital Ullevål Norway 27.8.2012

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

as the cause of recurrent syncope 3 allows appropriate management aimed

as the cause of recurrent syncope 3 allows appropriate management aimed Case Report Hellenic J Cardiol 2009; 50: 155-159 The Role of the Implantable Loop Recorder in the Investigation of Recurrent Syncope SKEVOS K. SIDERIS 1, TERESA A. MOUSIAMA 1, PAVLOS N. STOUGIANNOS 1,

More information

file://c:\documents and Settings\admin\My Documents\CV\92.htm

file://c:\documents and Settings\admin\My Documents\CV\92.htm Page 1 of 5 Amir Farjam Fazelifar, M.D. Assistant Professor of Cardiac Electrophysiology Academic Address: Shaheed Rajaei Cardiovascular, Medical & Research Center, Vali- Asr Avenue Tehran- Iran Tel /

More information

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan

More information

DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI

DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, G. PAPANIKOLAOU GH, THESSALONIKI The Impact of AF on Natural History of CAD DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI CAD MOST COMMON CARDIOVASCULAR DISEASE MOST COMMON CAUSE OF DEATH

More information

CLINICAL INVESTIGATIONS

CLINICAL INVESTIGATIONS 1312 Sarasin et al. d RISK SCORE FOR PREDICTING ARRHYTHMIAS CLINICAL INVESTIGATIONS A Risk Score to Predict Arrhythmias in Patients with Unexplained Syncope FrançoisP.Sarasin,MD,MSc,BarbaraH.Hanusa,PhD,ThomasPerneger,MD,PhD,

More information

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Clinical Policy: Holter Monitors Reference Number: CP.MP.113 Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of

More information

Condition Congestive heart failure I11.0; I13.0; I13.2; I42.0; I50 CO3C Left ventricular dysfunction I50.1; I50.9 E11 1; E11 9

Condition Congestive heart failure I11.0; I13.0; I13.2; I42.0; I50 CO3C Left ventricular dysfunction I50.1; I50.9 E11 1; E11 9 Comparative effectiveness and safety of non-vitamin K antagonists oral anticoagulants (OACs) and warfarin in daily clinical practice: A propensity weighted nationwide cohort study. Supplementary material

More information

National Horizon Scanning Centre. Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation

National Horizon Scanning Centre. Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation August 2008 This technology summary is based on information available at the time of

More information

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter

More information

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for

More information

Clinical Case 1 A patient with a syncope Panos E. Vardas President Elect of the ESC, Prof of Cardiology, University Hospital of Crete

Clinical Case 1 A patient with a syncope Panos E. Vardas President Elect of the ESC, Prof of Cardiology, University Hospital of Crete Clinical Case 1 A patient with a syncope Panos E. Vardas President Elect of the ESC, Prof. of Cardiology, University Hospital of Crete Case presentation A 64-year-old male smoker, with arterial hypertension

More information

Syncope Guidelines: What s New?

Syncope Guidelines: What s New? Syncope Guidelines: What s New? Dr. Samuel Asirvatham Professor of Medicine and Pediatrics Mayo Clinic College of Medicine Medical Director, Electrophysiology Laboratory Program Director, EP Fellowship

More information

The University of Mississippi School of Pharmacy

The University of Mississippi School of Pharmacy LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.

More information

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Financial disclosures Consultant Medtronic 3 reasons to evaluate and treat arrhythmias

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD The prevalence of cardiovascular disease is 68.8% among patients aged 66 and older who have CKD, compared to 34.1% among those who do not have CKD

More information

L. Fauchier (1), S. Taillandier (1), I. Lagrenade (1), C. Pellegrin (1), L. Gorin (1), A. Bernard (1), B. Rauzy (1), D. Babuty (1), GYL.

L. Fauchier (1), S. Taillandier (1), I. Lagrenade (1), C. Pellegrin (1), L. Gorin (1), A. Bernard (1), B. Rauzy (1), D. Babuty (1), GYL. Prognosis in patients with atrial fibrillation and CHA 2 DS 2 VASc score=0 in a real world community based cohort study: Loire Valley Atrial Fibrillation project L. Fauchier (1), S. Taillandier (1), I.

More information

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without

More information

Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri

Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri Original Research Article Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri P. Sasikumar * Department of General Medicine, Govt.

More information

Review guidance for patients on long-term amiodarone treatment

Review guidance for patients on long-term amiodarone treatment Review guidance for patients on long-term amiodarone treatment This review guidance document has been produced in response to: 1. Current supply shortages of branded and generic versions of 100mg and 200mg

More information

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX

More information

Exercise treadmill testing is frequently used in clinical practice to

Exercise treadmill testing is frequently used in clinical practice to Preventive Cardiology FEATURE Case Report 55 Commentary 59 Exercise capacity on treadmill predicts future cardiac events Pamela N. Peterson, MD, MSPH 1-3 David J. Magid, MD, MPH 3 P. Michael Ho, MD, PhD

More information

OAC after apparently successfull AF ablation: when, why, and how?

OAC after apparently successfull AF ablation: when, why, and how? Gulf EP Live 2015 - Dubai January 22-24 / 2015 OAC after apparently successfull AF ablation: when, why, and how? Antonio Raviele, MD, FESC, FHRS Past Director Cardiovascular Department, dell Angelo Hospital,

More information

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF

More information

Innovation therapy in Heart Failure

Innovation therapy in Heart Failure Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure

More information

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham Chest pain and troponins on the acute take J N Townend Queen Elizabeth Hospital Birmingham 3 rd Universal Definition of Myocardial Infarction Type 1: Spontaneous MI related to atherosclerotic plaque rupture

More information

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation The pill-in-the-pocket strategy for paroxysmal atrial fibrillation KONSTANTINOS P. LETSAS, MD, FEHRA LABORATORY OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL OF ATHENS ARRHYTHMIAS UPDATE,

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor

More information

Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and Pace Therapy Utilizing Biventricular Pacing

Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and Pace Therapy Utilizing Biventricular Pacing The Journal of Innovations in Cardiac Rhythm Management, 3 (2012), 976 981 HEART FAILURE RESEARCH ARTICLE Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and

More information

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals Goals Learn to coordinate a variety of data from multiple cardiovascular sub-disciplines, e.g. catheterization laboratory, hemodynamic study, non-invasive imaging, nuclear, electrophysiologic, and in combination

More information

Heart Failure (HF) Treatment

Heart Failure (HF) Treatment Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and

More information

Single living predicts a higher mortality in both women and men with chronic heart failure Mard, Shan; Nielsen, Finn Erland

Single living predicts a higher mortality in both women and men with chronic heart failure Mard, Shan; Nielsen, Finn Erland Syddansk Universitet Single living predicts a higher mortality in both women and men with chronic heart failure Mard, Shan; Nielsen, Finn Erland Published in: Danish Medical Journal Publication date: 2016

More information

NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT

NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities

More information

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011 Surgery and device intervention for the elderly with heart failure: assessing the need Devices and Technology for heart failure in 2011 Assessing cardiovascular function / prognosis (in the elderly): composite

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Svanström H, Pasternak B, Hviid A. Use of azithromycin and

More information

Chapter 4: Cardiovascular Disease in Patients with CKD

Chapter 4: Cardiovascular Disease in Patients with CKD Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%

More information

Mission Statement for our Arrhythmia Care

Mission Statement for our Arrhythmia Care Mission Statement for our Arrhythmia Care We are dedicated to provide a compassionate and an outstanding care for patients with cardiac arrhythmias. We will be utilizing the cutting edge and the most advanced

More information

Improving Patient Outcomes with a Syncope Center. Suneet Mittal, MD

Improving Patient Outcomes with a Syncope Center. Suneet Mittal, MD Improving Patient Outcomes with a Syncope Center Suneet Mittal, MD Improving Patient Outcomes with a Syncope Center: Early Risk Stratification of Patients who Require Device Therapy Suneet Mittal, MD Director,

More information

Results from RE-LY and RELY-ABLE

Results from RE-LY and RELY-ABLE Results from RE-LY and RELY-ABLE Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in longterm stroke prevention EXECUTIVE SUMMARY Dabigatran etexilate (Pradaxa ) has shown a consistent

More information

Death after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013

Death after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013 Death after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013 Death after Syncope: Can we predict it? Those who suffer from frequent and severe fainting often die suddenly

More information

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes Cardiovasc Drugs Ther (2017) 31:545 549 DOI 10.1007/s10557-017-6754-x ORIGINAL ARTICLE Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes

More information

Heart Rhythm Disorders. How do you quantify risk?

Heart Rhythm Disorders. How do you quantify risk? Heart Rhythm Disorders How do you quantify risk? Heart Rhythm Disorders Scale of the Problem 1/2 population will have an episode of transient loss of consciousness (T-LOC) at some stage in their life.

More information

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Dr. Antonio Magaña M.D. (on behalf I-PREFER investigators group) Stockholm, Sweden, August

More information

The Author(s) This article is published with open access by ASEAN Federation of Cardiology

The Author(s) This article is published with open access by ASEAN Federation of Cardiology DOI 10.7603/s40602-014-0011-3 ASEAN Heart Journal http://www.aseanheartjournal.org/ Vol. 22, no. 1, 60 65 (2014) ISSN: 2315-4551 Erratum Erratum to: Impact Of Sex On Clinical Characteristics And In-Hospital

More information

The American Experience

The American Experience The American Experience Jay F. Piccirillo, MD, FACS, CPI Department of Otolaryngology Washington University School of Medicine St. Louis, Missouri, USA Acknowledgement Dorina Kallogjeri, MD, MPH- Senior

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for

More information

Course: Exercise and Aging for Special Populations

Course: Exercise and Aging for Special Populations Copyright EFS Inc. All Rights Reserved. Course: Exercise and Aging for Special Populations Session 2: Cardiovascular and Metabolic Disease Considerations for Exercise Program Design Presentation Created

More information

Management of new-onset AF: Initial rate control treatment

Management of new-onset AF: Initial rate control treatment Geneva Acute Crdiovascular Care Congress 2014 - October 18-20, 2014 Management of new-onset AF: Initial rate control treatment Antonio Raviele, MD, FESC, FHRS ALFA Alliance to Fight Atrial fibrillation,

More information

DVLA Medical Questionnaire

DVLA Medical Questionnaire DVLA Medical Questionnaire Your Name: DOB: Today s Date: 2016 - www.countryhealth.co.uk Contents Introduction Key Client Information Important notes Vision assessment Health questionnaire Nervous system

More information

Syncope. A Symptom not a Diagnosis. Vijay Duggirala, MD

Syncope. A Symptom not a Diagnosis. Vijay Duggirala, MD Syncope A Symptom not a Diagnosis Vijay Duggirala, MD Assistant Professor-Clinical Department of Internal Medicine Division of Hospital Medicine The Ohio State University Wexner Medical Center Objectives

More information

National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008

National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008 Irbesartan (Aprovel) for heart failure with preserved systolic function August 2008 This technology summary is based on information available at the time of research and a limited literature search. It

More information

Syncope: Evaluation of the Weak and Dizzy

Syncope: Evaluation of the Weak and Dizzy Syncope: Evaluation of the Weak and Dizzy William M. Miles, MD, FACC, FHRS Professor of Medicine Silverstein Chair for Cardiovascular Education University of Florida College of Medicine Disclosures Medtronic,

More information

The MAIN-COMPARE Registry

The MAIN-COMPARE Registry Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Syncope. Philip B Vaidyan MD, FACP Department of Medicine St. Mary's Health Center

Syncope. Philip B Vaidyan MD, FACP Department of Medicine St. Mary's Health Center Syncope Philip B Vaidyan MD, FACP Department of Medicine St. Mary's Health Center I have no conflicts of interest to disclose Definition Syncope is a symptom, the defining clinical characteristics of which

More information

Syncope: Evaluation of the Weak and Dizzy

Syncope: Evaluation of the Weak and Dizzy Syncope: Evaluation of the Weak and Dizzy William M. Miles, MD, FACC, FHRS Professor of Medicine Silverstein Chair for Cardiovascular Education University of Florida College of Medicine Disclosures Medtronic,

More information

Manuel Castella MD PhD Hospital Clínic, University of

Manuel Castella MD PhD Hospital Clínic, University of Manuel Castella MD PhD Hospital Clínic, University of Barcelona mcaste@clinic.ub.es @mcastellamd www.escardio.org/guidelines European Heart Journal - doi:10.1093/eurheartj/ehw210 Providing integrated care

More information

Consensus Core Set: Cardiovascular Measures Version 1.0

Consensus Core Set: Cardiovascular Measures Version 1.0 Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized

More information

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention

More information

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39 Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often

More information

Heart failure hospitalizations with preserved or reduced ejection fraction

Heart failure hospitalizations with preserved or reduced ejection fraction Clinical profile and in-hospital outcomes in patients admitted for heart failure with preserved or reduced ejection fraction. EPI-CARDIO prospective registry Tajer, C; Mariani, J; de Abreu, M; Charask,

More information

S yncope may be defined as a sudden loss of consciousness,

S yncope may be defined as a sudden loss of consciousness, 23 ORIGINAL ARTICLE Risk stratification of patients with syncope in an accident and emergency department S D Crane...... S D Crane, Accident and Emergency Department, St James University Hospital, Leeds,

More information

Apixaban for stroke prevention in atrial fibrillation. August 2010

Apixaban for stroke prevention in atrial fibrillation. August 2010 Apixaban for stroke prevention in atrial fibrillation August 2010 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars on the 3 rd Wednesday of each month to address topics related to risk adjustment

More information

Diagnostic and therapeutic management of the patient with syncope M. Brignole Arrhythmologic Centre and Syncope Unit Lavagna, Italy

Diagnostic and therapeutic management of the patient with syncope M. Brignole Arrhythmologic Centre and Syncope Unit Lavagna, Italy Diagnostic and therapeutic management of the patient with syncope M. Brignole Arrhythmologic Centre and Syncope Unit Lavagna, Italy Eur Heart J. 2009 Nov;30(21):2631-71 Available on www.escardio.org/guidelines

More information

CLINICAL PRACTICE GUIDELINE

CLINICAL PRACTICE GUIDELINE CLINICAL PRACTICE GUIDELINE Procedure: Congestive Heart Failure Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

More information

Cardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski

Cardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski Cardiac arrhythmias Janusz Witowski Department of Pathophysiology Poznan University of Medical Sciences A 68-year old man presents to the emergency department late one evening complaining of increasing

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of

More information

Gerasimos Filippatos MD, FESC, FCCP, FACC

Gerasimos Filippatos MD, FESC, FCCP, FACC Gerasimos Filippatos MD, FESC, FCCP, FACC Head of HF Unit at Athens University Hospital, Greece President (2014-2016) of the HF Association of the European Society of Cardiology (ESC) Served as Chair of

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information